Next week there will be 55 shares of banning, banning the total market value of more than 50 billion yuan.
Fund heavy stocks fell one after another
GuoLian shares yesterday, low opening low, and finally closed with a drop. Previously, Guolian shares had been questioned suspected of financial fraud, on November 25 and November 28 for two consecutive trading days fell.
December 1 after-hours, GuoLian shares in response to the SSE inquiry letter, said the company has been media reports on financing trade, per capita revenue generation abnormalities, the use of fund-raising and other matters have been carefully verified to confirm that the foregoing is not true, and the relevant disclosure of the previous period of truth, accuracy, and completeness of all material aspects.
According to yesterday's after-hours LW list data, the Shanghai Stock Exchange special seat bought the stock 103 million yuan and sold 48,089,100 yuan, 3 institutions net buy 201 million yuan, 2 institutions net sell 163 million yuan.
GuoLian Stock is a B2B e-commerce and industrial Internet platform. 2022 three quarterly report shows that the company in the first three quarters of the operating income of 46.286 billion yuan, an increase of 97.17% year-on-year; maternal net profit of 683 million yuan, an increase of 101.57% year-on-year.
From the financial data from 2017 to 2021, GuoLian Stock has maintained high double-digit growth in revenue and net profit. The market performance is also stronger, the company's share price has been shocked up since its listing in 2019, once soared 22 times, and ushered in the stock's all-time high of 131.75 yuan per share on Nov. 22nd.
For the recent decline in share price, the company through shareholders to increase holdings in an attempt to boost market confidence.November 30 after-hours announcement shows that Guolian shares controlling shareholders, de facto controllers, directors, supervisors and company management personnel intends to increase the company's shares in the six months from November 29, 2022, the amount of the proposed increase of not less than 50.2 million yuan and not more than 100.4 million yuan.
GuoLian shares are the heavy positions of public funds, as of the end of the third quarter of 2022, *** there are 65 institutions hold shares of GuoLian shares. Among them, 60 fund companies hold a total of about 112 million shares, accounting for 22.48% of the company's outstanding shares. The top holdings include GF, CBI Schroder, Hong Kong Securities Clearing Company Limited and Nanfang Fund.
Guangfa Fund has the highest number of holdings, with nine of its products holding Guolian shares, and the five products with the highest number of holdings are all managed by Liu Ge-siong, a well-known fund manager, and are GF Technology Pioneer Mix, GF Small Cap Growth Mix (FOF), GF Twin Prime Upgrade Mix, GF Innovation Upgrade Flexible Allocation Mix, and GF Diversified Emerging Stocks, with a combined holding of 40.342 million shares.
The total market value of Liu Gesheng's fund holdings currently stands at 3.946 billion yuan, shrinking by a combined 1.142 billion yuan from the Nov. 24 close. The market value of CB Schroder's and Harvest's holdings shrunk by RMB523 million and RMB350 million from the Nov. 24 close, respectively.
Next week, the market value of more than 50 billion yuan
Securities Times - Data Treasure statistics, next week there will be 55 shares of the release; according to the latest closing price, the total market value of 55.506 billion yuan. 11 shares of the release of more than 1 billion yuan, Bairen medical, North China, China Merchants cumulative balance, Xiangsheng medical Medicine, the North China, China Merchants cumulative balance, Xiangsheng medical, the release of market value of 1 billion yuan. /strong>The market value of the release of the top.
The largest market value is Bai Ren Medical, next week there will be 101 million shares listed for circulation, mainly for the original shareholders of the first restricted shares, the market value of 14.05 billion yuan.
22 shares of the release of less pressure, the release of market value are less than 100 million yuan. Among them Youyou food, Lexin technology, Xinrui technology the market value of the release of less than ten million.
5 shares of the proportion of more than 50%
Data treasure statistics, 5 shares of the number of shares of the total share capital ratio of more than 50%, respectively, Xiangsheng medical, Bairen medical, the new Dazheng, Meide medical, Zhuo Yi information . Among them, Xiangsheng medical the largest proportion of the release of the number of shares accounted for 74.92% of the total share capital, next week there will be 0.84 billion shares listed in circulation, the market value of the release of about 3.119 billion yuan.
The number of shares released accounted for less than 1% of the total share capital of 15 shares. Among them, YauYau Foods, Loxin Technology, Xinrui Technology and other 6 shares of the proportion of the release of less than 0.1%.
Eve of the ban, more than the performance of the stock performance
Data treasure statistics, next week will be released of the 55 shares, since November, the average stock price rose 7.5%, losing the same period of the broader market. During the cumulative increase of more than 10% of the 19 shares, San Fu Xinke the largest increase, since November cumulative rise of 53.24%. Long into the technology, Meditech, new Fengming the top gainers.
From the performance data, these stocks, 50 shares realized profits. Shengxin lithium the first three quarters of net profit reached 4.35 billion yuan, in next week's release of stocks in the first place profit.
In addition, Wellsong Intelligence, Shengxin lithium energy, Renesas technology and other 7 shares in the first three quarters of the results show double growth.